Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FL1BR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,410
Award facts
- Contract value 100% obligated
- $37,409.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $37,410 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 20, 2026, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This firm fixed-price delivery order, which is not set aside for small businesses or other designated groups, is scheduled for completion by January 21, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used in HIV treatment, reflecting the Defense Logistics Agency's ongoing pharmaceutical supply requirements for military medical facilities and healthcare systems.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s (UEI: NWEGNLYTBDW4) larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion vehicle extending through December 31, 2031. This comprehensive IDC enables the pharmaceutical distributor to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions globally. The contract vehicle demonstrates AmerisourceBergen's significant role as a critical supplier within the federal pharmaceutical supply chain and its capacity to fulfill competitive procurement requirements for essential medical products across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FL1BR?
SPE2DR26FL1BR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FL1BR worth?
The government has obligated $37,410 on SPE2DR26FL1BR.
Is contract SPE2DR26FL1BR an order under another contract?
Yes. SPE2DR26FL1BR is a delivery order under SPE2DR25D3401, an indefinite delivery contract.
Was contract SPE2DR26FL1BR competed?
The extent of competition for SPE2DR26FL1BR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award